Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB

Objectives: We compared the pharmacokinetics of moxifloxacin during rifampicin co-treatment or when dosed alone in African patients with drug-susceptible recurrent TB. Methods: Patients in the intervention arm of the Improving Retreatment Success (IMPRESS) randomized controlled TB trial received 400...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Antimicrob Chemother
Autors principals: Naidoo, Anushka, Chirehwa, Maxwell, McIlleron, Helen, Naidoo, Kogieleum, Essack, Sabiha, Yende-Zuma, Nonhlanhla, Kimba-Phongi, Eddy, Adamson, John, Govender, Katya, Padayatchi, Nesri, Denti, Paolo
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890691/
https://ncbi.nlm.nih.gov/pubmed/28175315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars